Learn why these key experts can help optimize ANCA-associated vasculitis management.

Rituximab and cyclophosphamide are equally effective in achieving remission or low disease activity rates in childhood-onset antineutrophil cytoplasmic antibody–associated vasculitis (AAV), and those ...

Renal function at the time of antineutrophil cytoplasmic antibody-associated vasculitis diagnosis was significantly associated with renal function at 1 year. Children with antineutrophil cytoplasmic ...

Leukocytoclastic vasculitis is characterized by inflammation directed at small blood vessels in the skin. The process is mediated by neutrophils. Histologically, leukocytoclasis (i.e., destruction of ...